Clinical Trials Directory

Trials / Completed

CompletedNCT00817622

Effects of EPA and Vitamin E on Leptin, Adiponectin and Enzymatic Antioxidants in Type 2 DM

Effects of EPA Alone and Combined With Vitamin E on Blood Leptin, Adiponectin and Enzymatic Antioxidants Levels in Type II Diabetic Patients; A Randomized, Double-Blind, Placebo-Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
129 (actual)
Sponsor
Tehran University of Medical Sciences · Academic / Other
Sex
All
Age
30 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate efficacy and safety of EPA(Eicosapentaenoic Acid)alone and with VitE in diabetic patients.

Detailed description

Randomized, double-blind, placebo-controlled, parallel-group study design After a 12weeks, subjects with type II DM will be randomized to receive either 2000 mg pearl EPA per day plus a double-blinded matching placebo (1 corn oil pearls per day) for 12 weeks OR 400 mg VitE pearl plus double-blinded per day plus a double-blinded matching placebo (4 corn oil pearls per day) for 12 weeks OR 2000 mg pearl EPA per day plus a double-blinded matching 400 mg VitE pearl OR placebo(4corn oil pearls per day plus 1 corn oil pearls per day )for 12 weeks.The total dose of EPA pearl will be 2000 mg per day (with the EPA or matching placebo corn oil doses remaining at 4 pearls per day) and The total dose of VitE pearl will be 400 mg per day (with the VitE or matching placebo corn oil doses remaining at 1 pearls per day).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTEPA, Vitamin EEPA pearls, 500 mg QID for 12 Weeks (2000 mg per day) Vitamin E pearls, 400 mg per day for 12 weeks

Timeline

Start date
2007-01-01
Primary completion
2009-06-01
Completion
2009-09-01
First posted
2009-01-06
Last updated
2009-11-18

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT00817622. Inclusion in this directory is not an endorsement.